Wl. Gross et al., New perspectives in pulmonary angiitis - From pulmonary angiitis and granulomatosis to ANCA associated vasculitis, SARCO VASC, 17(1), 2000, pp. 33-52
Traditionally clinical and histopathological features were mainly relied on
for classification of vasculitis and granulomatosis of the lung. These can
be complemented by immunodiagnostic features which contribute to the class
ification as well as to the understanding of the pathogenesis of these diso
rders. Previously five conditions were classified together under the headin
g "pulmonary angiitis and granulomatosis" (PA & G), mainly on the basis of
histological similarities. These conditions have in common a granulomatous
histopathology together with necrosis of varying degree, pulmonary vasculit
is and occasionally systemic vasculitis. The introduction of novel immunodi
agnostic methods led to different approaches of classification, specificall
y a separation between a group of disorders associated with antinuclear ant
ibodies (ANA), referred to as collagen vascular diseases, and a group of sy
stemic autoimmune diseases unrelated to ANA, referred to as primary systemi
c vasculitides. Among the latter Wegener's granulomatosis (WG), Churg-Strau
ss syndrome (CSS) and microscopic polyangiitis (MPA) are associated with a
group of autoantibodies (antineutrophil cytoplasmic antibodies-ANCA) which
separate them from other members of the PA & G group. The granulomatous and
vasculitic disorders WG and CSS together with the non-granulomatous small-
vessel vasculitis MPA now form a new group of diseases ('ANCA-associated va
sculitides') which have many clinical, serological and immunohistochemical
features in common. Collagen vascular diseases (CVD) are serologically char
acterized by distinct subspecificities of antinuclear antibodies (ANA), som
etimes pronounced hypergammaglobulinaemia, complement consumption and immun
e deposits (antigen-antibody-complement complexes) which are common in situ
in immune-complex vasculitis. In this article newer aspects of the clinica
l course, the immunodiagnostic procedure, and the immunopathogenesis of the
relatively large group of pulmonary angiitis will be described.